Stericycle, Inc. (NASDAQ:SRCL) PT Set at $108.00 by Jefferies Group LLC

Stericycle, Inc. (NASDAQ:SRCL) has been given a $108.00 target price by stock analysts at Jefferies Group LLC in a report released on Friday. The brokerage presently has a “buy” rating on the business services provider’s stock. Jefferies Group LLC’s price target would suggest a potential upside of 52.05% from the company’s current price.

A number of other brokerages have also recently issued reports on SRCL. Zacks Investment Research upgraded shares of Stericycle from a “hold” rating to a “buy” rating and set a $97.00 price objective for the company in a report on Tuesday, April 25th. Robert W. Baird cut shares of Stericycle from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $74.00 to $73.00 in a report on Friday, May 5th. Deutsche Bank AG decreased their price target on shares of Stericycle from $14.00 to $10.00 and set a “buy” rating for the company in a report on Monday, May 15th. Barclays PLC started coverage on shares of Stericycle in a report on Thursday, April 13th. They set an “overweight” rating and a $100.00 price target for the company. Finally, BMO Capital Markets started coverage on shares of Stericycle in a report on Thursday, June 29th. They set a “market perform” rating and a $81.00 price target for the company. Four research analysts have rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company. The company has an average rating of “Hold” and an average price target of $81.15.

Stericycle (NASDAQ SRCL) opened at 71.03 on Friday. The firm’s market cap is $6.06 billion. The firm’s 50 day moving average price is $76.45 and its 200-day moving average price is $80.44. Stericycle has a 52 week low of $70.24 and a 52 week high of $88.00.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, August 3rd. The business services provider reported $1.15 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.13 by $0.02. The firm had revenue of $917.70 million during the quarter, compared to analysts’ expectations of $902.81 million. Stericycle had a negative net margin of 0.07% and a positive return on equity of 14.35%. Stericycle’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.18 earnings per share. On average, analysts forecast that Stericycle will post $4.60 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This article was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at https://www.com-unik.info/2017/08/12/stericycle-inc-nasdaqsrcl-pt-set-at-108-00-by-jefferies-group-llc.html.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Kernodle & Katon Asset Management Group LLC purchased a new stake in Stericycle during the first quarter valued at $100,000. Heritage Trust Co purchased a new stake in Stericycle during the first quarter valued at $124,000. Pacer Advisors Inc. raised its stake in Stericycle by 3.3% in the first quarter. Pacer Advisors Inc. now owns 1,735 shares of the business services provider’s stock valued at $144,000 after buying an additional 55 shares during the last quarter. Invictus RG purchased a new stake in Stericycle during the first quarter valued at $145,000. Finally, Morgan Dempsey Capital Management LLC raised its stake in Stericycle by 2.6% in the first quarter. Morgan Dempsey Capital Management LLC now owns 1,902 shares of the business services provider’s stock valued at $158,000 after buying an additional 48 shares during the last quarter. 95.16% of the stock is owned by hedge funds and other institutional investors.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

What are top analysts saying about Stericycle Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Stericycle Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit